Symptom effects
In three studies (Murray et al., 1998; Robion et al., 2001; Céleste et al., 2005), the authors determined if corticosteroids injected in normal joints would cause any drawbacks, such as signs of lameness or joint effusion. No significant changes regarding these outcomes were found after injections of MPA or TA.